CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-22 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-02-22 | Bancel Stephane Chief Executive Officer | Sale | −10,472 | $157.87 | $1.7M | 5,441,474 |
| 2023-02-22 | Bancel Stephane Chief Executive Officer | Sale | −20,303 | $158.53 | $3.2M | 5,421,171 |
| 2023-02-22 | Bancel Stephane Chief Executive Officer | Sale | −8,725 | $159.59 | $1.4M | 5,412,446 |
| 2023-02-22 | Bancel Stephane Chief Executive Officer | Sale | −500 | $160.28 | $80K | 5,411,946 |
| 2023-02-22 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,427,155 | ||
| 2023-02-22 | AFEYAN NOUBAR Director | Sale | −10,000 | $160.35 | $1.6M | 2,197,209 |
| 2023-02-16 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-02-16 | Bancel Stephane Chief Executive Officer | Sale | −8,952 | $172.14 | $1.5M | 5,442,994 |
| 2023-02-16 | Bancel Stephane Chief Executive Officer | Sale | −28,331 | $173.30 | $4.9M | 5,414,663 |
| 2023-02-16 | Bancel Stephane Chief Executive Officer | Sale | −2,717 | $173.79 | $472K | 5,411,946 |
| 2023-02-16 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,467,155 | ||
| 2023-02-15 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-02-15 | Bancel Stephane Chief Executive Officer | Sale | −10,327 | $173.68 | $1.8M | 5,441,619 |
| 2023-02-15 | Bancel Stephane Chief Executive Officer | Sale | −13,375 | $174.77 | $2.3M | 5,428,244 |
| 2023-02-15 | Bancel Stephane Chief Executive Officer | Sale | −14,812 | $175.85 | $2.6M | 5,413,432 |
| 2023-02-15 | Bancel Stephane Chief Executive Officer | Sale | −1,486 | $176.73 | $263K | 5,411,946 |
| 2023-02-15 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,507,155 | ||
| 2023-02-15 | AFEYAN NOUBAR Director | Sale | −10,000 | $173.17 | $1.7M | 2,207,209 |
| 2023-02-10 | Hoge Stephen President | Sale | −245 | $163.90 | $40K | 1,627,693 |
Page 56 of 66 · 1,314 trades